5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. [electronic resource]
Producer: 20050831Description: 566-74 p. digitalISSN:- 0022-1767
- AMP-Activated Protein Kinases
- Aminoimidazole Carboxamide -- analogs & derivatives
- Animals
- Antigen Presentation -- drug effects
- Cytokines -- metabolism
- DNA-Binding Proteins -- biosynthesis
- Encephalomyelitis, Autoimmune, Experimental -- drug therapy
- Enzyme Activation -- drug effects
- Female
- GATA3 Transcription Factor
- Glycoproteins -- immunology
- Humans
- Immunologic Factors -- therapeutic use
- Interleukin-10 -- biosynthesis
- Mice
- Mice, Inbred C57BL
- Multienzyme Complexes -- metabolism
- Multiple Sclerosis -- drug therapy
- Myelin Proteolipid Protein -- immunology
- Myelin-Oligodendrocyte Glycoprotein
- Peptide Fragments -- immunology
- Protein Serine-Threonine Kinases -- metabolism
- Ribonucleotides -- therapeutic use
- T-Box Domain Proteins
- Th1 Cells -- drug effects
- Th2 Cells -- drug effects
- Trans-Activators -- biosynthesis
- Transcription Factors -- antagonists & inhibitors
- T-bet Transcription Factor
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.